Baxter International, Global Medical Response and Cardinal Health provided the latest round of funding for Boston-based Medically Home, joining Mayo Clinic and Kaiser Permanente as strategic partners.
The supply chain needs of the pharmaceutical industry are growing increasingly complex, particularly with the growth of cell and gene therapies that require timely delivery of medication components that have to be kept at stable temperatures.
A new report, Resilience in volatility: Modernizing the supply chain from Microsoft highlights factors that have stressed the supply chain over the past 18 months and how companies are responding to this crisis as they lay the groundwork to minimize the impact of global events in the future.
INVEST 2022 is going to be held March 28-30 in at the Ritz Carlton hotel in Chicago. This year, we have four new categories reflecting the pandemic-reality and how it has reshaped healthcare. Apply now for a chance to pitch LIVE in front of VC judges. Please note that companies that have pitched in the last 12 months at a MedCity event are ineligible to apply. Selected finalists will be asked to register for the conference at a reduced rate. Deadline is January 15.
The field of biotechs pursuing new interleukin-2 cancer immunotherapies is filled with companies engineering different versions of that signaling protein. Avenge Bio CEO Mike Heffernan said his startup stands apart with a cell therapy that produces human IL-2 that could offer advantages compared to engineered versions of that protein.
If you can achieve the right mix of high-tech, high-touch options, you've hit the sweet spot for improving equity and accessibility, patient engagement, health outcomes, loyalty, and profitability
Every company will eventually face an audit. Download this FREE general audit checklist to evaluate your organization and take proactive steps guaranteed to prepare you in order pass an audit when the time comes.
No comments